SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: j_fir2 who wrote (2573)4/30/1999 2:22:00 PM
From: Art Vandelay AIA  Respond to of 10280
 
Actually, I don't think it is so much selling. The big selling was Southwell's divorce, which she will grow to regret (maybe not divorcing him, but at least having sold in the 50's).

It reminds me of an old joke - next time I'm not going to get married. I'm just going to find the one woman I hate most and go up to her and give her a house.

Other than that, there hasn't been much. IR says that there are a few directors who ahve bought houses. Of note to me is that only one sale has occurred since the precipitous decline from the 130s, which tells me that the insiders think we're under, not overvalued.

Have a nice weekend...



To: j_fir2 who wrote (2573)4/30/1999 3:03:00 PM
From: wolfdog2  Read Replies (1) | Respond to of 10280
 
ugah, ugah. We've been torpedoed and we're going down. Man all posts. Water's flooding into the front engines. We're sinking.



To: j_fir2 who wrote (2573)4/30/1999 4:26:00 PM
From: Andreas Helke  Read Replies (1) | Respond to of 10280
 
If I had too many Sepracor shares as some of those insiders seem to have I would have loved to sell some of them above $120. Since I have just 100 shares bought about 1 year ago for $39 I am just patiently waiting for a new buying opportunity. If I had free money I would start buying right now. Since I don't have that I will probably raise money by selling something else if Sepracor drops below $75.

In my experience it is perfectly normal for a development stage biotech company to go down 50% from its all time high even if there are no disastrous news. Sepracor is not a biotech but it is similar in having a few more years of big losses. Therefore I always expected that we would see the type of downside move that we have right now.

I have restricted my current SEPR shares from selling for a few more years.

Andreas